Marc Wiesenberger analyst

Currently out of the existing stock ratings of Marc Wiesenberger, 67 are a BUY (91.78%), 6 are a HOLD (8.22%).

Marc Wiesenberger

Work Performance Price Targets & Ratings Chart

Analyst Marc Wiesenberger, currently employed carries an average stock price target met ratio of 51.46% that have a potential upside of 67.19% achieved within 183 days.

Marc Wiesenberger’s has documented 134 price targets and ratings displayed on 13 stocks. The coverage was on Healthcare, Industrials, Technology, Communication Services sectors.

Most recent stock forecast was given on SMLR, Semler Scientific at 02-Nov-2022.

Wall Street Analyst Marc Wiesenberger

Analyst best performing recommendations are on ZYXI (ZYNEX).
The best stock recommendation documented was for ZYXI (ZYNEX) at 10/28/2022. The price target of $12.5 was fulfilled within 5 days with a profit of $1.98 (18.82%) receiving and performance score of 37.64.

Average potential price target upside

BLFS BioLife Solutions DHX DHI Group LFMD LifeMD NEPH Nephros NSIT Insight Enterprises OESX Orion Energy Systems SMLR Semler Scientific ZYXI Zynex OPRX OPTIMIZERx Corp AUGX Augmedix AVGR Avinger LPTH LightPath Technologies LOV Spark Networks SE

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$33

$5.61 (20.48%)

$30

10 days ago
(13-Dec-2024)

3/5 (60%)

$6.54 (24.72%)

69

Buy

$32

$4.61 (16.83%)

$30

1 months 10 days ago
(13-Nov-2024)

2/5 (40%)

$4.39 (15.90%)

268

Buy

$28

$0.61 (2.23%)

$32

4 months 14 days ago
(09-Aug-2024)

4/10 (40%)

$2.75 (10.89%)

136

Buy

$15

$-12.39 (-45.24%)

$15

11 months 15 days ago
(08-Jan-2024)

6/7 (85.71%)

$-2.24 (-12.99%)

185

Buy

$20

$-7.39 (-26.98%)

$25

1 years 2 months 3 days ago
(20-Oct-2023)

2/5 (40%)

$9.8 (96.08%)

286

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Marc Wiesenberger?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?